In short: Around a fifth to a quarter of people with a learning disability also have epilepsy, compared with roughly 1 in 100 of the general population, and their seizures are far more likely to resist treatment. The 2024 LeDeR annual report found epilepsy accounted for 9.4% of avoidable deaths among adults with a learning…

In short: Oxcarbazepine, sold in the UK under the brand name Trileptal and as generic versions, is an anti-seizure medication (ASM) used for focal seizures. Most early side effects are dose-related and often settle, but oxcarbazepine has one distinctive risk worth understanding: low blood sodium, known as hyponatraemia. Skin reactions also need prompt attention, particularly…